UF’s Sid Martin Biotech Named Top Global Incubator for Record Third Time

For the third time, the International Business Innovation Association (InBIA) has awarded its highest honor – the Randall M. Whaley Incubator of the Year award – to UF Innovate | Sid Martin Biotech. “Being named the best incubator on the planet is amazing. Receiving this award three times in a decade speaks volumes to the […]

Oxidien Pharmaceuticals Receives High Recognition at RESI Conference in Partnership With Women in Bio

UF Innovate | The Hub resident client Oxidien Pharmaceuticals, a clinical-stage biopharmaceutical company mitigating kidney disease by treating secondary hyperoxaluria, announced that its compelling investment opportunity was recognized by conference attendees casting their votes for the company in the Innovation Challenge. The votes cast for Oxidien placed the company in the top three in the impressive […]

How to Create a COVID-19 Vaccine

Alan Joslyn Ph.D. president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, speaks with James Di Virgilio, Radio Cade podcast co-host, about COVID-19 vaccine challenges and explore Oragenics journey from idea generation to COVID-19 […]

UF Ranked No. 1 Nationally in Innovation Impact

The University of Florida is the most productive large university in the country at leveraging its research funding into new companies, new jobs and new ideas, according to a report released last week by the George W. Bush Institute and the Opus Faveo Innovation Development consulting firm. A team of economists and business development experts […]

AGTC Announces Significant Productivity and Quality Enhancement to Its Proprietary Manufacturing Process

UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, provided an update on the continued productivity and quality improvements made in its proprietary manufacturing platform that is currently being used […]

Morphogenesis Seeks Skin Cancer Patients for New Clinical Trials

Known for developing personalized immunotherapies for the treatment of cancer through novel cell and gene therapies, UF startup and UF Innovate | Sid Martin Biotech alumni company Morphogenesis, Inc., has received FDA approval to expand its human clinical trials into two more types of cancer. Using its ImmuneFx (IFx) cancer vaccine technology that initiates the power […]

AGTC Launches Nationwide Mobile Vision Testing Program for Patients Enrolled in Its Ongoing Phase 1/2 Clinical Trials

UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced the launch of an innovative mobile vision testing program to conduct follow-up assessments during the COVID-19 pandemic for patients enrolled […]

UF Innovate | The Hub Celebrates 10 Years Since Groundbreaking

UF Innovate | The Hub is a place where entrepreneurs take a creative idea and make it into a legitimate business. In the past 10 years, 108 businesses began their journey there. “There wasn’t any real formal support for entrepreneurs and first-time startup founders in the Gainesville area. This was a real boom for providing […]